Activation of Interleukin-1 Beta in Arterialized Vein Grafts and the Influence of the -511C/T IL-1 beta Gene Polymorphism

Carregando...
Imagem de Miniatura
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
MDPI
Citação
JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, v.6, n.2, article ID 20, 8p, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The interleukin-1 family is associated with innate immunity and inflammation. The latter has been linked to the genesis of cardiovascular diseases. We, therefore, investigated whether interleukin-1 beta (IL-1 beta) is activated during arterialization of vein grafts. First, we examined the activation of IL-1 beta using the rat arterialized jugular vein serially sampled for up to 90 days. IL-1 beta expression increased 18 times on day 1 in the arterialized rat jugular vein and remained five times above nonarterialized vein levels for up to 90 days. Similarly, IL-1 beta expression increased early (1-5 days) in human vein graft autopsy samples compared with late phases (1-4 years). Activation was also detected in ex vivo arterialized human saphenous veins. Upon stratification of the results, we uncovered a T allele promoter attenuating effect in IL-1 beta activation in response to hemodynamic stress. Altogether, the results show that IL-1 beta is activated during arterialization of vein grafts in rats and humans, and this response is modulated by -511C/T IL-1 beta gene polymorphism. It is tempting to speculate that the activation of IL-1 beta, and consequently local inflammation, modulates early vascular remodeling and that the gene polymorphism may be useful in predicting outcomes or assisting in interventions.
Palavras-chave
human saphenous vein, interleukin-1 beta, vein graft, gene polymorphisms
Referências
  1. Baylis RA, 2017, ARTERIOSCL THROM VAS, V37, pE174, DOI 10.1161/ATVBAHA.117.310097
  2. Body SC, 2009, CIRC-CARDIOVASC GENE, V2, P499, DOI 10.1161/CIRCGENETICS.109.849075
  3. Borin TF, 2009, INT J EXP PATHOL, V90, P328, DOI 10.1111/j.1365-2613.2009.00648.x
  4. Christiansen JF, 2004, ANN THORAC SURG, V77, P1575, DOI 10.1016/j.athoracsur.2003.10.107
  5. de Vries MR, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00003
  6. Epstein H, 2008, ATHEROSCLEROSIS, V199, P41, DOI 10.1016/j.atherosclerosis.2007.10.034
  7. Faries PL, 1996, J VASC SURG, V24, P463, DOI 10.1016/S0741-5214(96)70203-3
  8. Fukui T, 2015, EUR J CARDIO-THORAC, V47, P66, DOI 10.1093/ejcts/ezu045
  9. Gomez D, 2018, NAT MED, V24, P1418, DOI 10.1038/s41591-018-0124-5
  10. Guo HA, 2004, IMMUNOL LETT, V91, P159, DOI 10.1016/j.imlet.2003.11.009
  11. Iacoviello L, 2005, ARTERIOSCL THROM VAS, V25, P222, DOI 10.1161/01.ATV.0000150039.60906.02
  12. Jiang ZH, 2004, J VASC SURG, V40, P345, DOI 10.1016/j.jvs.2004.03.048
  13. Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3
  14. Marculescu R, 2003, THROMB HAEMOSTASIS, V90, P491, DOI 10.1160/TH03-01-0064
  15. Miyakawa AA, 2008, CLINICS, V63, P683, DOI 10.1590/S1807-59322008000500018
  16. Muehlschlegel JD, 2010, CIRCULATION, V122, pS60, DOI 10.1161/CIRCULATIONAHA.109.924233
  17. Murillo LS, 2003, HUM REPROD, V18, P2309, DOI 10.1093/humrep/deg436
  18. Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7
  19. Owens CD, 2015, J VASC SURG, V61, P203, DOI 10.1016/j.jvs.2013.08.019
  20. Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914
  21. Ridker PM, 2018, LANCET, V391, P319, DOI 10.1016/S0140-6736(17)32814-3
  22. Ridker PM, 2017, EUR HEART J, V38, P3545, DOI 10.1093/eurheartj/ehx723
  23. Rogus J, 2008, HUM GENET, V123, P387, DOI 10.1007/s00439-008-0488-6
  24. Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207
  25. Toumpoulis IK, 2004, EUR J CARDIO-THORAC, V25, P51, DOI 10.1016/S1010-7940(03)00651-1
  26. von der Thusen JH, 2003, PHARMACOL REV, V55, P133, DOI 10.1124/pr.55.1.5
  27. Wang XK, 2000, BIOCHEM BIOPH RES CO, V271, P138, DOI 10.1006/bbrc.2000.2588
  28. Ward AO, 2017, ATHEROSCLEROSIS, V265, P266, DOI 10.1016/j.atherosclerosis.2017.08.023
  29. Yayla C, 2016, ANGIOLOGY, V67, P133, DOI 10.1177/0003319715578258
  30. Yu P, 2013, SURGERY, V153, P63, DOI 10.1016/j.surg.2012.06.005